Biosimilars A New Generation of Biologics /
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular co...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Prugnaud, Jean-Louis (Editor), Trouvin, Jean-Hugues (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Paris :
Springer Paris : Imprint: Springer,
2013.
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
Published: (2017) -
The New Drug Reimbursement Game A Regulator’s Guide to Playing and Winning /
by: Pekarsky, Brita A.K
Published: (2015) -
Biosimilars Regulatory, Clinical, and Biopharmaceutical Development /
Published: (2018) -
Drug Interactions in Infectious Diseases
Published: (2011) -
From Molecular to Modular Tumor Therapy Tumors are Reconstructible Communicatively Evolving Systems /
Published: (2010)